Video
Dr. Koo on diversity, equity, and inclusion in urology drug trials
Author(s):
“I think the take home message of this study is that there's work to do, and that our efforts in diversity, equity, and inclusion extends broadly beyond simply ensuring that we have the workforce to treat our diverse population, or that urologists are thinking critically and responsibly about the needs of our patients,” says Kevin Koo, MD, MPH.
In this video, Kevin Koo, MD, MPH, shares the take-home message from the study, “Disparities in race and ethnicity reporting in contemporary clinical trials leading to new drug approvals in urology,” which was presented at the North Central Section of the American Urological Association Annual Meeting in Chicago, Illinois. Koo is a urologist at Mayo Clinic in Rochester, Minnesota.
Related Videos
Related Content
